GENFIT Launches a Phase 2 Trial Evaluating Elafibranor

June 10, 2019

Study objective to determine the effect of elafibranor, a dual PPAR alpha/delta agonist, on fatty acid saturationPhase 2 study to evaluate the effect of a 6-week, once daily treatment of elafibranor (120mg) vs. placebo on hepatic lipid composition in patients with Nonalcoholic Fatty Liver (NAFL)State of the art non invasive techniques (H-MRS) to be used to provide indications on both quantitative and qualitative evolution of liver fat

Spotlight

Central Maine Healthcare

Central Maine Healthcare (CMH) serves 400,000 people in the central, western, and mid-coast regions of the state. One flagship medical center, two rural, critical access hospitals and an extensive variety of primary and specialty care practices located in 14 communities throughout the region make up the CMH system.

OTHER WHITEPAPERS
news image

AN ASSESSMENT OF THE FEDERAL GOVERNMENT’S FINANCIAL RISKS TO CLIMATE CHANGE

whitePaper | April 15, 2022

The climate crisis poses a serious threat to the United States economy and human welfare, with a narrowing timeframe to invest in opportunities to avoid the most catastrophic impacts.

Read More
news image

2022 Healthcare Cyber Crime Update

whitePaper | August 12, 2022

Amid a growing array of threats, the healthcare industry is pummeled by hundreds of successful cyber attacks each year. Ransomware, business email compromise (BEC) and state-sponsored attacks are just a few of the threats that keep security teams awake at night.

Read More
news image

The relationship between cybersecurity ratings and therisk of hospital data breaches

whitePaper | January 31, 2022

We investigated the progression of healthcare cybersecurity over 2014–2019 as measured by external risk ratings. We further examined the relationship between hospital data breaches and cybersecurity ratings.

Read More
news image

Addressing Total Cost of Care Across the Specialty Population

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

Read More
news image

Test Resource

whitePaper | May 18, 2021

Test Resource The criteria of patient satisfaction have changed dramatically. The priority of your healthcare business is to provide patients the right treatment. But nowadays, you cannot excel in your service

Read More
news image

Clearing hurdles that crimp real-time and predictive insights in healthcare

whitePaper | July 26, 2022

Healthcare leaders have long recognized the importance of real-time decision making. Take, for instance, sepsis one of the leading causes of U.S. hospital deaths that costs the industry an estimated $62B a year,1 not to mention the preventable morbidity

Read More

Spotlight

Central Maine Healthcare

Central Maine Healthcare (CMH) serves 400,000 people in the central, western, and mid-coast regions of the state. One flagship medical center, two rural, critical access hospitals and an extensive variety of primary and specialty care practices located in 14 communities throughout the region make up the CMH system.

Events